SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is a trending topic following its latest financial results, which indicated pressure on gross margins and a decline in sales within the crucial China market, leading to a divided investor sentiment. The community is actively debating whether current valuations present a 'buy the dip' opportunity for the iconic brand or if intensifying competition and strategic challenges signal a prolonged period of underperformance.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as investors hotly debate a lawsuit filed against alleged manipulators, with strong opinions on whether management is effectively addressing stock undervaluation through promised buybacks. The community discussion also centers on the phased rollout of a large AI data center contract and a recent Nobel Sustainability Trust nomination, as many question market integrity and management's actions amidst persistent share price pressure.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. (WYFI) is trending due to a substantial new colocation agreement with Nscale for its NC-1 AI data center campus, which has ignited significant community excitement. Investors are actively discussing the deal's improved long-term revenue visibility, the potential for a short squeeze, and how the company's limited share float could drive considerable upside. This positions WhiteFiber as a key player in the rapidly expanding market for AI-ready data center capacity.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as the community eagerly anticipates potential federal cannabis rescheduling to Schedule III, a move widely expected to eliminate the burdensome 280E tax and unlock significant profitability for U.S. multi-state operators. Despite market volatility and some "sell the news" reactions, sentiment remains highly bullish, with investors highlighting GTBIF's strong fundamentals and growing presence in the cannabis beverage market as key drivers poised to attract institutional capital.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is actively discussed following the executive order to reclassify cannabis to Schedule III, a significant policy shift that the company is leveraging to advance its U.S. medical cannabis operations through its newly formed Tilray Medical USA unit. Despite sector-wide volatility interpreted by some as a "sell the news" event, many in the community emphasize the long-term benefits for profitability and institutional investment stemming from this historic regulatory change.

Kodiak AI, Inc. is a provider of AI-powered autonomous vehicle technology designed to help tackle some of the toughest driving jobs. Its solutions address the critical problem of safely transporting goods in the face of unprecedented supply chain challenges. The company was founded in 2018 and is headquartered in Mountain View, CA.

Kodiak AI Inc.

Kodiak AI Inc. - Ordinary Shares - Class A

Kodiak AI (KDK) is trending following a disclosed stake from Soros Fund Management and continued accumulation by institutions like Cathie Wood's ARK Invest, sparking significant community debate. Bulls highlight the company's active revenue generation from autonomous trucking contracts in the Permian Basin, a low share float, and high short interest as potential catalysts. Conversely, skeptics voice concerns over the company's financial health, long-term viability, and potential for further dilution.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is trending following an eight-figure contract win to provide spacecraft docking systems for The Exploration Company's Nyx capsule, igniting bullish sentiment around its space infrastructure capabilities. The community is actively discussing the stock's significant volume, viewing it as an undervalued play poised for growth as U.S. space policy and defense initiatives drive demand for commercial space and drone technologies into 2026.

PDD Holdings, Inc. is a multinational commerce group that owns and operates a portfolio of businesses. The company aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from increased productivity and new opportunities. It has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses. PDD Holdings was founded by Hua Lin Cai and Zheng Huang in 2015 and is headquartered in Dublin, Ireland.

PDD Holdings Inc - ADR

Pinduoduo Inc.

Pinduoduo is trending following its latest earnings insights, which showed stronger profitability but also highlighted concerns around moderated revenue growth and intensifying market competition. Community discussions reveal a strong underlying bullish sentiment, with many investors anticipating continued upside driven by global e-commerce expansion through Temu, despite the tempered outlook. This creates a fascinating divergence in perception, with significant options activity suggesting expectations for substantial price action.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending following key product announcements, including expanded prediction markets with new sports-focused event contracts and the introduction of an AI tool named Cortex. This strategic move is sparking community discussions around future revenue growth and diversification, though some members are weighing potential regulatory scrutiny concerning the nature of these prediction markets. Additionally, the stock is being influenced by recent analyst upgrades and broader market sentiment, including cryptocurrency performance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending following its significant acquisition of Cidara Therapeutics for an experimental flu drug, a strategic move reinforcing its pipeline beyond Keytruda. This development, coupled with multiple FDA fast-track designations and positive clinical data for other assets, has the community buzzing about Merck's robust future growth trajectory and increasing portfolio diversification.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 5.5% - Here's What Happened

Sana Biotechnology (NASDAQ:SANA) Stock Price Down 5.5% - Here's Why...

Marex Group plc Takes $10.42 Million Position in Sana Biotechnology, Inc. $SANA

Marex Group plc purchased a new stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine analysts that are covering the stock, MarketBeat Ratings reports...

Sana Biotechnology (NASDAQ:SANA) Trading Up 8.8% - Still a Buy?

Sana Biotechnology (NASDAQ:SANA) Shares Up 8.8% - Here's What Happened...

Sana Biotechnology (NASDAQ:SANA) Shares Down 5.9% - Time to Sell?

Sana Biotechnology (NASDAQ:SANA) Trading Down 5.9% - Should You Sell...

Sana Biotechnology (NASDAQ:SANA) Trading 12.8% Higher - Still a Buy?

Sana Biotechnology (NASDAQ:SANA) Shares Up 12.8% - Still a Buy...

Sana Biotechnology (NASDAQ:SANA) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered shares of Sana Biotechnology from a "hold" rating to a "sell" rating in a research report on Saturday...

Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Moderate Buy" by Brokerages

Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has been given an average rating of "Moderate Buy" by the nine brokerages that are covering the company, Marketbeat Ratings reports. One...

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.1% - Time to Sell?

Sana Biotechnology (NASDAQ:SANA) Trading Down 7.1% - Here's What Happened...

Top 3 Genomics Stocks to Consider for Your Portfolio

Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Sana Biotechnology Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.14	--	--	N/A
Q3 '25	-$0.19	-$0.16	15.23%	BEAT
Q2 '25	-$0.20	-$0.39	-94.27%	MISSED
Q1 '25	-$0.22	-$0.21	4.26%	BEAT
Q4 '24	-$0.25	-$0.21	16.56%	BEAT

SANA
Sana Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SANA News

SANASana Biotechnology Inc